Future Outlook of the Calquence Market in the Era of Precision Oncology
The Calquence Market is well-positioned for sustained growth as precision oncology becomes the standard of cancer care. Calquence’s targeted action and favorable safety profile make it a key component of modern treatment regimens. From a valuation of USD 2.5 Billion in 2023, the market is projected to grow to USD 20.6 Billion by 2030, registering a CAGR of 21.3% during 2024–2034....
0 Commentarios 0 Acciones 154 Views 0 Vista previa
Patrocinados